CoinsAQ summary · neutral
Kalshi and Polymarket now let you bet on drug approvals, and not everyone is thrilled about it
What happened
Prediction markets are expanding into biotech territory, raising thorny questions about insider trading, ethics, and whether wagering on clinical trials is actually a good idea You can now bet real money on whether the FDA will approve a drug. Kalshi launched a suite of biotech.
Related asset context
Not financial advice. News and sentiment can be incomplete, delayed, or change quickly.
Continue researching
Related stories
Tracked Binance wallets record $2.5 billion in outflows as withdrawals reopen after hack
Tracked Binance wallets recorded $2.5 billion in outflows as withdrawals reopened. New withdrawal wallets complicate estimates of customer exits.
Binance Starts Withdrawal Recovery as FBI Blames North Korea for $6B+ Hack
Deposits have remained available throughout the incident and were not affected, the company noted.
Aave reopens frozen markets but blocks new collateral loans
Aave’s cap cuts preserve earlier borrowing room, says LlamaRisk. Reserve cash, collateral rules and unresolved rate settings shape practical user access.